financetom
Personal Finance
financetom
/
Personal Finance
/
As 3 plans of 'Saral Jeevan Bima' go live; here's a comparison of their monthly premiums
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
As 3 plans of 'Saral Jeevan Bima' go live; here's a comparison of their monthly premiums
Feb 12, 2021 8:41 AM

Several insurance companies have launched 'Saral Jeevan Bima' plans with standard terms and conditions to allow customers to make an informed choice, as mandated by the Insurance Regulatory and Development Authority of India (IRDAI).

Live TV

Loading...

Under this plan, the minimum age of entry is 18 years and the maximum entry age is capped at 65 and the maximum maturity age is 70 years. The policy term extends from 5 to 40 years.

The product is available to individuals without restrictions on gender, place of residence, travel, occupation, or educational qualifications.

The minimum sum assured under the product is Rs 5 lakh, and the maximum can go up to Rs 25 lakh. Individuals are allowed to choose from regular premium payment throughout the policy term, single premium payment in lumpsum, or limited premium payment (5, 10 years) options.

According to Santosh Agarwal, CBO-Life Insurance, Policybazaar, the self-employed people with an annual income of Rs 3-5 lakh earlier were not able to get the term insurance due to the unavailability of income proof. Now when Saral Jeevan Bima (SJB) plans have launched, the chance of issuing a term insurance policy to this segment has improved.

"SJB provides the option of income surrogate where customers can submit the RC of their car or two-wheeler as a surrogate to their income proof. While the progress is going in the right direction, we expect the issuance rate to this segment to go up to 70 percent which was earlier only 30 percent. However, this will be a bit early to show some trends. So far we’ve seen traction around the self-employed people choosing SJB,” Agarwal opines.

Here's a comparison of 'Saral Jeevan Bima' plans of different insurers for a 35-year old male living in a metro city:

InsurerMonthly Premium
PNB Met LifeRs 849
Edelweiss Tokio LifeRs 1,139
Exide Life InsuranceRs 1,872

(Source: Policybazaar)

Disclaimer: The views and investment tips expressed by experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.

(Edited by : Jomy)

First Published:Feb 12, 2021 5:41 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Lifts Opinion On Shares Of Walmart Inc. To Strong Buy From Buy
Research Alert: CFRA Lifts Opinion On Shares Of Walmart Inc. To Strong Buy From Buy
Aug 21, 2025
01:45 PM EDT, 08/21/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target by $2 to $120, about 40x our FY 27 (Jan.) EPS of $2.99 (from $2.94; FY 26 to $2.68 from $2.66), a justifiable premium to...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Bilibili Inc.
Research Alert: CFRA Maintains Hold Opinion On Shares Of Bilibili Inc.
Aug 22, 2025
08:30 AM EDT, 08/22/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: ...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Bilibili Inc.
Research Alert: CFRA Maintains Hold Opinion On Shares Of Bilibili Inc.
Aug 22, 2025
09:15 AM EDT, 08/22/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our Hold opinion for Bilibili ( BILI ) and keep our 12-month target at USD25 based on 2.3x 2025 P/Revenue, reflecting better sentiment from strong H1 financial performance...
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novo Nordisk
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novo Nordisk
Aug 22, 2025
06:10 AM EDT, 08/22/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We adjust our target price to USD61 from USD49 implying 15.6x our 2025 EPADS, a discount to its historical forward P/E average of 25x-31x, justified in our view to reflect...
Copyright 2023-2026 - www.financetom.com All Rights Reserved